Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies ...
Stubby Clapp's school is in session as rookie infielder was already going through video and drills to increase his range at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results